Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Leveraging the Tumor Microenvironment for IO Therapy

  • Broadcast in Science
Pharma Talk Radio

Pharma Talk Radio

Featured Host
×  

Follow This Show

If you liked this show, you should follow Pharma Talk Radio.
h:548881
s:11690775
archived
Play
  • Host

First recorded at the 4th annual IO Combinations 360° conference, this talk provided by Dr Kenneth Hance, GSK addresses agonistic strategies, T and NK cell redirection and the use of genetic/phenotypic assocations to identify novel target space in IO.

To learn more about the upcoming IO Combinations 360° conference please visit, www.iocombinations360.com

Facebook comments

Available when logged-in to Facebook and if Targeting Cookies are enabled